INTERVENTIONAL CARDIOLOGY
Brachytherapy: Potential therapy for refractory coronary spasm
Paul Erne, MD*,*,
Peiman Jamshidi, MD*,
Peter Juelke, MD ,
Hans-Peter Hafner, PhD ,
Peter Thum, MD and
Therese Resink, PhD
* Cardiology
Radiotherapy, Kantonsspital Luzern, LuzernSwitzerland
Department of Research, Kantonsspital Basel, Basel, Switzerland
Manuscript received May 14, 2004;
revised manuscript received June 8, 2004,
accepted June 22, 2004.
* Reprint requests and correspondence: Dr. Paul Erne, Division of Cardiology, Kantonsspital Luzern, 6006 Luzern 16, Switzerland (Email: Paul.Erne{at}KSL.CH).
OBJECTIVES: We sought to demonstrate that brachytherapy reduces coronary spasm in refractory and highly symptomatic variant angina.
BACKGROUND: In some patients with variant angina due to extensive vasoconstriction, intensive drug therapy fails to sufficiently relieve symptoms.
METHODS: In 18 patients with frequent angina episodes despite triple anti-anginal therapy, coronary spasm was induced by intracoronary acetylcholine (ACh) infusion. Five patients had spasm in a second vessel. Intracoronary radiation (20 Gy) was applied to vasospastic segments using a beta-emitting (32P) wire source centered within a Galileo balloon. Parameters of vessel function before and after brachytherapy were investigated.
RESULTS: Before brachytherapy, artery diameters decreased (p < 0.0001) from 2.8 ± 0.4 mm to 1.0 ± 0.4 mm for the first vessels and from 3.1 ± 0.3 mm to 1.0 ± 0.2 mm for the second vessels. After brachytherapy (143 ± 106 and 80 ± 52 days for first and second vessels, respectively), ACh-induced vasoconstriction was significantly reduced. The ACh-induced changes in artery diameter before and after brachytherapy were 1.5 ± 0.5 mm and 0.5 ± 0.3 mm (p < 0.0001) for the first vessels and 1.4 ± 0.3 mm and 0.4 ± 0.2 mm (p < 0.01) for the second vessels, respectively. In non-irradiated spastic vessels, ACh-induced vasoconstriction remained unchanged (e.g., 1.7 ± 0.6 mm, 1.6 ± 0.3 mm, and 1.5 ± 0.5 mm for second vessels, at first investigation, first follow-up, and immediately before brachytherapy, respectively). Angina frequency decreased from 15.6 ± 6.0 to 2.2 ± 2.4 angina episodes/week (p < 0.001) in treated patients.
CONCLUSIONS: Brachytherapy is a potential therapy in patients with highly symptomatic variant angina.
|
Abbreviations and Acronyms
| | ACh = acetylcholine | | CFR = coronary flow reserve | | +dv/dt = flow acceleration rate | | dv/dt = flow deceleration rate | | LAD = left anterior descending |
|
|